A new healthcare giant is here! CVS has closed a 69-billion merger with Aetna, the nation’s third-largest health insurer. The companies have recently announced that all necessary approvals had been obtained (New York was the last state to sign off on the deal).

Several states opposed the merger due to potential antitrust issues (federal regulatory

In attempt to counterbalance Amazon, Walmart has recently signed a deal with Anthem to provide Medicare enrollees with over-the-counter medications and health supplies at its stores.

For quite some time, Walmart has been making advances in the healthcare sector. For example, it already provides eye care at roughly 3,000 in-store vision centers and free health

Walgreens has entered into agreement with DaVita to purchase its non-dialysis related prescription files, mostly under Medicare Part D. Currently, DaVita uses a drug distribution facility in Orlando for dispensing by mail non-dialysis medications. The deal with Walgreens is scheduled to finalize in late September, at which time the files of the facility will be

I have been closely watching Amazon’s attempts to enter pharmaceutical market,[1] but even for me, Amazon’s acquisition of PillPack came as a surprise.

For those not familiar with PillPack (which has its headquarters on the East Coast), it specializes in single-dose medication packing, deliveries, and prescription management targeting chronic-disease patients. It acts as an online

For the last year, both Lyft and Uber have been working with healthcare providers and insurers offering rides to doctors’ offices. Last week, Lyft announced that it is expanding its partnerships with health care providers by partnering with Allscripts to “integrate its platform into the daily routines of 2,500 hospitals, 45,000 physician practices and 180,000

Amazon hasn’t launched its prescription mail order program yet, but the effects of its potential market entry are already being felt across the industry. Thus, CVS has announced that it will “begin offering next-day delivery of prescription drugs and same-day service in some big cities next year, reflecting the company’s worries about potential competition from

The proposed $66-billion merger between CVS and Aetna – the most expensive healthcare deal to date – may cut down drug prices by eliminating the middlemen. The proposed deal is covered in depth by various publications. For example, Bloomberg News suggests that the merger could be the end of the pharmacy-benefit business. Reuters reports that